Tripureswari Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
- Paid Up Capital ₹ 0.50 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Revenue Growth -25.76%
- Profit Growth 4.26%
- Ebitda -80.95%
- Net Worth 89.14%
- Total Assets -9.26%
About Tripureswari Bio-Tech
Tripureswari Bio-Tech Private Limited (TBPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 2011 and has a history of 13 years and ten months. Its registered office is in Tripura, Tripura, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Swapan Debnath and Barna Debnath serve as directors at the Company.
Company Details
-
Location
Tripura, Tripura, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TR2011PTC008321
-
Company No.
008321
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Tripureswari Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Debnath
|
Director | 29-Mar-2011 | Current |
|
Barna Debnath
|
Director | 01-Dec-2012 | Current |
Financial Performance of Tripureswari Bio-Tech.
Tripureswari Bio-Tech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.76% decrease. The company also saw a slight improvement in profitability, with a 4.26% increase in profit. The company's net worth Soared by an impressive increase of 89.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tripureswari Bio-Tech?
In 2019, Tripureswari Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2014 | United Bank Of India | ₹1.00 Cr | Open |
How Many Employees Work at Tripureswari Bio-Tech?
Unlock and access historical data on people associated with Tripureswari Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tripureswari Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tripureswari Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
